The adverse events (AEs) were systematically classified in accordance with the Common Terminology Criteria for Adverse Events, version 5.0 (CTCAE v5.0).Results:A total of 37 patients were included; 56.8% were Child-Pugh A and 43.2% were Child-Pugh B. Treatment regimens prior to regorafenib and...
ORR and DCR in this study were analyzed according to the results of the best overall response evaluated during the treatment of lenvatinib plus PD-1 blockades. Furthermore, safety profile was analyzed using Common Terminology Criteria for Adverse Events (CTCAE) version 5.0...
M. et al. From NAFLD to MAFLD: implications of a premature change in terminology. Hepatology https://doi.org/10.1002/hep.31420 (2020). Article PubMed Google Scholar Global Burden of Disease Liver Cancer Collaboration et al. The burden of primary liver cancer and underlying etiologies from ...
patients become refractory to available medical therapy for a period of time before they died and most of them suffered from severe symptom burden. Management of hepatic pain is challenging. Opioid is commonly prescribed in controlling cancer pain; however, in patients...
WHAT'HS OT Fast Track Programs International Culture & Language Industry Specific Languages Medical Programs LEAN Enterprise Technology Solutions TCTCBusiness and Management Conflict Resolution Harnessing the Power of Conflict ... 4 I'm OK - You're Difficult... 4 Moving From Conflict to Collaboration...
Imaging techniques play a crucial role in the management of patients with liver cirrhosis in whom a nodular hepatic lesion is detected. The most severe com
Notable-HCC (NCT05185531) is a phase 1b trial, aiming to evaluate the safety and preliminary effectiveness of neoadjuvant PD-1 blockade plus stereotactic body radiotherapy (SBRT) in early-stage resectable hepatocellular carcinoma (HCC). Twenty patients with HCC of BCLC stage 0-A received 3Gy SBR...
Background: Despite the wide development of 90Y-loaded microspheres, 188Re-labeled lipiodol is still being used for radioembolization of hepatocellular carcinoma (HCC). However, the use of this latter compound is limited by in vivo instability. This stud